Tri-Ad™ 2.0 Adams tricuspid annuloplasty band, Model 900SFC
![]() |
|
Photos courtesy of Dr. David Adams, Mount Sinai Hospital, New York
In this retrospective study, 42 consecutive patients who underwent concomitant tricuspid repair with the Tri-Ad™ 2.0 platform were analyzed — predischarge TTE revealed absent or minimal tricuspid regurgitation (TR) in all patients, while no ring-related operative complications were observed. Also, no patient required a permanent pacemaker implantation.
In this retrospective, single-center study, 36 patients undergoing tricuspid repair with the Tri-Ad™ 2.0 platform were analyzed. Tricuspid annuloplasty with the Tri-Ad™ 2.0 platform corrected functional tricuspid regurgitation effectively and provided good early clinical and echocardiographic results without ring-related complications. Specifically, no patient required a permanent pacemaker implantation.
Key risks of tricuspid annuloplasty include recurrent regurgitation, stenosis, and ring dehiscence.
![]() |
|
| Item number | Description |
|---|---|
| T7900P | Tri-Ad™ 2.0 tray |
| 7900PS | Set of 6 Tri-Ad™ 2.0 sizers (26–36 mm) |
| 7686 | Annuloplasty handle (216 mm) |
| 7686L | Annuloplasty handle (254 mm) |
| 7686XL | Annuloplasty handle (373 mm) |
We do not review or control the content of external sites and are not responsible for any interactions or transactions that may occur there. Any product availability and regulatory requirements on the destination site may differ depending on your location. When you continue, the terms of use and privacy statement of the external site will apply.
Product availability and regulatory requirements may differ depending on your location. The destination website is governed by the laws and regulations of the country in which it operates, which may be different from those in your country. When you continue, the terms of use and privacy statement of the destination Medtronic site will apply.